5-Amino-1MQ

A small-molecule NNMT inhibitor, not a peptide, marketed alongside peptides and studied for metabolic effects in rodents.

What research shows

5-Amino-1MQ is a small molecule NNMT inhibitor, not a peptide, although it is sold alongside peptides. The verified evidence is preclinical: selective NNMT inhibitors were developed and characterized in laboratory studies, and NNMT inhibition improved obesity-related metabolic measures in rodents. No published human trials of this compound were verified.

Evidence strength

Highest evidence grade among the graded claims: C. Grades reflect study strength, not benefit.

Safety context

See the safety section. Absence of a flag is not evidence of safety.

No endorsement

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.